START FREE TRIAL

OpenAI Introduces ChatGPT Ads & Gemini’s Monetization Plan Suddenly Looks Critical!

OpenAI (NASDAQ:GOOGL) just made the next big move in the AI race. OpenAI introduces ChatGPT ads this year, starting with tests in the U.S. in the coming weeks. These ads will show up for free-tier users. Paid plans like Plus, Pro, Business, and Enterprise will stay ad-free. The ads are expected to appear at the bottom of answers, clearly labeled, and separate from the response. OpenAI says ads won’t change how ChatGPT answers questions. It also says ads won’t show for users expected to be under 18, and won’t appear near sensitive topics like health, mental health, or politics.

This matters because it looks a lot like Search monetization, but inside a chat interface. That is where Google makes its money. And Google already knows it. It’s pushing AI Overviews, AI Mode, and new ad formats that sit inside AI answers. The next phase is clear: more AI shopping, more sponsored placements, and more paid Gemini tiers.

ChatGPT Ads Open New Revenue Stream While Keeping Core Answers Separate

OpenAI introduces ChatGPT ads with a structure that looks intentionally “non-intrusive.” The ads are planned to sit at the bottom of answers, and OpenAI says…

Continue Reading With Our 7-Day Free Trial

ONLY $10 per month after the trial. Cancel anytime. No sponsors. No conflicts. 100% independent stock research.

Recent Articles

Amazon Just Paid BILLIONS For Glass. The AI Bottleneck NOBODY Is Talking About!

On Monday, Amazon announced a multiyear, multibillion-dollar agreement with...

Did Ingredion Find A Mispriced Path Into Higher-Value Ingredients?

Ingredion (NYSE:INGR) has moved into deal mode with a...

Incyte Acquisition Watch: The $2 Billion Star Therapeutics Deal That Could Change Its Story

Incyte Corporation (NASDAQ:INCY) is back in the biotech deal...

Is SpaceX Asking $1.75 Trillion For A Company Truly Worth NO MORE THAN $780 Billion?

The largest IPO in history just launched its roadshow....

Related Articles

Amazon Just Paid BILLIONS For Glass. The AI Bottleneck NOBODY Is Talking About!

On Monday, Amazon announced a multiyear, multibillion-dollar agreement with...

Did Ingredion Find A Mispriced Path Into Higher-Value Ingredients?

Ingredion (NYSE:INGR) has moved into deal mode with a...

Incyte Acquisition Watch: The $2 Billion Star Therapeutics Deal That Could Change Its Story

Incyte Corporation (NASDAQ:INCY) is back in the biotech deal...

Broadcom Said 3 Words That Killed The Narrative: “WE ARE CHIPS ONLY!”A

Let's do the math quickly. Broadcom (NASDAQ:AVGO) just reported $10.8...

Berkshire Paid BELOW Market for Alphabet & the Stock Fell; Who’s WRONG?

Let's start with the weird part. On Monday, Alphabet (NASDAQ:...
spot_img

Related Articles

Popular Categories

spot_imgspot_img